Comparison of the efficacy of equivalent doses of dexamethasone, methylprednisolone, and hydrocortisone for treatment of COVID-19-related acute respiratory distress syndrome: a prospective three-arm randomized clinical trial

BACKGROUND: This prospective controlled clinical trial aimed to compare the efficacy of methylprednisolone, dexamethasone, and hydrocortisone at equivalent doses in patients with severe COVID-19. METHODS: In total, 106 patients with mild to moderate COVID-19-related acute respiratory distress syndro...

Descripción completa

Detalles Bibliográficos
Autores principales: Taher, Abbas, Lashkari, Marjan, Keramat, Fariba, Hashemi, Seyyed Hamid, Sedighi, Ladan, Poorolajal, Jalal, Mehrpooya, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838299/
https://www.ncbi.nlm.nih.gov/pubmed/36624180
http://dx.doi.org/10.1007/s10354-022-00993-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838299/
https://www.ncbi.nlm.nih.gov/pubmed/36624180
http://dx.doi.org/10.1007/s10354-022-00993-4

Ejemplares similares